The Cleveland Clinic recently reported the results of a study of oral immunotherapy in children ages under age four with peanut and other food allergies. Although there has been limited data on outcomes in this age group, this study found that 95% of children were successfully treated with OIT up to a full dose of 2 peanuts for those on peanut OIT. Side effects were not common and the frequency of reactions needing epinephrine was only 2%, which is much lower than observed in older children. The previous NIH IMPACT study also reported similar promising outcomes in children ages one to three. This is yet another study suggesting that OIT is especially safe and effective in very young children.
